Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C24H30FO9P.2Na |
| Molecular Weight | 558.4413 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 8 / 8 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].[Na+].CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COP([O-])([O-])=O
InChI
InChIKey=XCMJCLDAGKYHPP-AREPQIRLSA-L
InChI=1S/C24H32FO9P.2Na/c1-20(2)33-19-10-16-15-6-5-13-9-14(26)7-8-21(13,3)23(15,25)17(27)11-22(16,4)24(19,34-20)18(28)12-32-35(29,30)31;;/h7-9,15-17,19,27H,5-6,10-12H2,1-4H3,(H2,29,30,31);;/q;2*+1/p-2/t15-,16-,17-,19+,21-,22-,23-,24+;;/m0../s1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/17088419
Sources: https://www.ncbi.nlm.nih.gov/pubmed/17088419
Triamcinolone acetonide- 21-dihydrogen phosphate is the long-acting derivative of a synthetic glucocorticoid triamcinolone. Triamcinolone acetonide has eight times more potency than prednisolone. Triamcinolone acetonide- 21-dihydrogen phosphate used for intravenous injection. It is supposed to be hydrolyzed rapidly in the body to form the free corticoid alcohol.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/17088419
Curator's Comment: Dogs data
Single injection - 0.2 mg/kg
Route of Administration:
Intravenous
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C521
Created by
admin on Mon Mar 31 17:33:57 GMT 2025 , Edited by admin on Mon Mar 31 17:33:57 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
CHEMBL2111162
Created by
admin on Mon Mar 31 17:33:57 GMT 2025 , Edited by admin on Mon Mar 31 17:33:57 GMT 2025
|
PRIMARY | |||
|
100000175600
Created by
admin on Mon Mar 31 17:33:57 GMT 2025 , Edited by admin on Mon Mar 31 17:33:57 GMT 2025
|
PRIMARY | |||
|
16147
Created by
admin on Mon Mar 31 17:33:57 GMT 2025 , Edited by admin on Mon Mar 31 17:33:57 GMT 2025
|
PRIMARY | |||
|
1997-15-5
Created by
admin on Mon Mar 31 17:33:57 GMT 2025 , Edited by admin on Mon Mar 31 17:33:57 GMT 2025
|
PRIMARY | |||
|
C152734
Created by
admin on Mon Mar 31 17:33:57 GMT 2025 , Edited by admin on Mon Mar 31 17:33:57 GMT 2025
|
PRIMARY | |||
|
DTXSID30941876
Created by
admin on Mon Mar 31 17:33:57 GMT 2025 , Edited by admin on Mon Mar 31 17:33:57 GMT 2025
|
PRIMARY | |||
|
m11028
Created by
admin on Mon Mar 31 17:33:57 GMT 2025 , Edited by admin on Mon Mar 31 17:33:57 GMT 2025
|
PRIMARY | Merck Index | ||
|
R2MZ7K74S8
Created by
admin on Mon Mar 31 17:33:57 GMT 2025 , Edited by admin on Mon Mar 31 17:33:57 GMT 2025
|
PRIMARY | |||
|
217-878-8
Created by
admin on Mon Mar 31 17:33:57 GMT 2025 , Edited by admin on Mon Mar 31 17:33:57 GMT 2025
|
PRIMARY |
SUBSTANCE RECORD